Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tesofensine + metoprolol second 12-week open-label extension in Prader-Willi syndrome
2016-003694-18Phase 2Completed
- Sponsor
- Saniona
- Start
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of tesofensine and metoprolol in Prader-Willi syndrome (PWS), sponsored by Saniona. Primary endpoint: Percent change in mean body weight. Started Oct 2016; status: completed.
02
Drugs
tesofensinemetoprolol
03
Conditions
Prader-Willi syndrome (PWS)
Beyond the preview
Go deeper on 2016-003694-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-003694-18.